ClinicalTrials.gov record
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
ClinicalTrials.gov ID: NCT03587805
Public ClinicalTrials.gov record NCT03587805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Multi-centre, Long-term Extension Trial to Evaluate the Safety and Efficacy of Tralokinumab in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Clinical Trials
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.
Study identification
- NCT ID
- NCT03587805
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,672 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2018 (Actual)
- Primary completion
- Jul 3, 2024 (Actual)
- Completion
- Jul 3, 2024 (Actual)
- Last update posted
- Mar 11, 2025
2018 – 2024
United States locations
- U.S. sites
- 95
- U.S. states
- 30
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| LEO Pharma Investigational Site | Birmingham | Alabama | 35209 | — |
| LEO Pharma Investigational Site | Birmingham | Alabama | 35233 | — |
| LEO Pharma Investigational Site | Mobile | Alabama | 36695 | — |
| LEO Pharma Investigational Site | Fort Smith | Arkansas | 72916 | — |
| LEO Pharma Investigational Site | Bakersfield | California | 93301 | — |
| LEO Pharma Investigational Site | Beverly Hills | California | 90212 | — |
| LEO Pharma Investigational Site | Encinitas | California | 92024 | — |
| LEO Pharma Investigational Site | Fountain Valley | California | 92708 | — |
| LEO Pharma Investigational Site | Fremont | California | 94538 | — |
| LEO Pharma Investigational Site | Fullerton | California | 92835 | — |
| LEO Pharma Investigational Site | Los Angeles | California | 90025 | — |
| LEO Pharma Investigational Site | Los Angeles | California | 90033 | — |
| LEO Pharma Investigational Site | Los Angeles | California | 90045 | — |
| LEO Pharma Investigational Site | Newport Beach | California | 92660 | — |
| LEO Pharma Investigational Site | Northridge | California | 91324 | — |
| LEO Pharma Investigational Site | Palo Alto | California | 94304 | — |
| LEO Pharma Investigational Site | San Diego | California | 92119 | — |
| LEO Pharma Investigational Site | San Diego | California | 92123 | — |
| LEO Pharma Investigational Site | San Francisco | California | 94132 | — |
| LEO Pharma Investigational Site | San Luis Obispo | California | 93405 | — |
| LEO Pharma Investigational Site | Santa Ana | California | 92701 | — |
| LEO Pharma Investigational Site | Santa Monica | California | 90404 | — |
| LEO Pharma Investigational Site | New Haven | Connecticut | 06519 | — |
| LEO Pharma Investigational Site | Clearwater | Florida | 33756 | — |
| LEO Pharma Investigational Site | Doral | Florida | 33122 | — |
| LEO Pharma Investigational Site | Hialeah | Florida | 33012 | — |
| LEO Pharma Investigational Site | Miami | Florida | 33015 | — |
| LEO Pharma Investigational Site 1 | Miami | Florida | 33144 | — |
| LEO Pharma Investigational Site 2 | Miami | Florida | 33144 | — |
| LEO Pharma Investigational Site | North Miami Beach | Florida | 33162 | — |
| LEO Pharma Investigational Site | Orange Park | Florida | 32073 | — |
| LEO Pharma Investigational Site | Sweetwater | Florida | 33172 | — |
| LEO Pharma Investigational Site | Tampa | Florida | 33614 | — |
| LEO Pharma Investigational Site | West Palm Beach | Florida | 33401 | — |
| LEO Pharma Investigational Site | West Palm Beach | Florida | 33406 | — |
| LEO Pharma Investigational Site | Albany | Georgia | 31707 | — |
| LEO Pharma Investigational Site | Columbus | Georgia | 31904 | — |
| LEO Pharma Investigational Site | Macon | Georgia | 31217 | — |
| LEO Pharma Investigational Site | Newnan | Georgia | 30263 | — |
| LEO Pharma Investigational Site | Savannah | Georgia | 31406 | — |
| LEO Pharma Investigational Site | Chicago | Illinois | 60611 | — |
| LEO Pharma Investigational Site | Clarksville | Indiana | 47129 | — |
| LEO Pharma Investigational Site | Indianapolis | Indiana | 46250 | — |
| LEO Pharma Investigational Site | Plainfield | Indiana | 46168 | — |
| LEO Pharma Investigational Site | Overland Park | Kansas | 66215 | — |
| LEO Pharma Investigational Site | Louisville | Kentucky | 40215 | — |
| LEO Pharma Investigational Site | Louisville | Kentucky | 40217 | — |
| LEO Pharma Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| LEO Pharma Investigational Site | Lake Charles | Louisiana | 70601 | — |
| LEO Pharma Investigational Site | Bangor | Maine | 04401 | — |
| LEO Pharma Investigational Site | Boston | Massachusetts | 02115 | — |
| LEO Pharma Investigational Site | Brighton | Massachusetts | 02135 | — |
| LEO Pharma Investigational Site | Quincy | Massachusetts | 02169 | — |
| LEO Pharma Investigational Site | Ann Arbor | Michigan | 48103 | — |
| LEO Pharma Investigational Site | Detroit | Michigan | 48202 | — |
| LEO Pharma Investigational Site | Troy | Michigan | 48084 | — |
| LEO Pharma Investigational Site | West Bloomfield | Michigan | 48322 | — |
| LEO Pharma Investigational Site | Ypsilanti | Michigan | 48197 | — |
| LEO Pharma Investigational Site | Saint Joseph | Missouri | 64506 | — |
| LEO Pharma Investigational Site | Missoula | Montana | 59808 | — |
| LEO Pharma Investigational Site | Henderson | Nevada | 89074 | — |
| LEO Pharma Investigational Site | East Windsor | New Jersey | 08520 | — |
| LEO Pharma Investigational Site | Buffalo | New York | 14203 | — |
| LEO Pharma Investigational Site | Cortland | New York | 13045 | — |
| LEO Pharma Investigational Site | Horseheads | New York | 14845 | — |
| LEO Pharma Investigational Site | Kew Gardens | New York | 11415 | — |
| LEO Pharma Investigational Site | New York | New York | 10021 | — |
| LEO Pharma Investigational Site | New York | New York | 10022 | — |
| LEO Pharma Investigational Site | New York | New York | 10028 | — |
| LEO Pharma Investigational Site | New York | New York | 10075 | — |
| LEO Pharma Investigational Site | Raleigh | North Carolina | 27612 | — |
| LEO Pharma Investigational Site | Bexley | Ohio | 43209 | — |
| LEO Pharma Investigational Site | Cincinnati | Ohio | 45219 | — |
| LEO Pharma Investigational Site | Cincinnati | Ohio | 45231 | — |
| LEO Pharma Investigational Site | Dublin | Ohio | 43016 | — |
| LEO Pharma Investigational Site | Fairborn | Ohio | 45324 | — |
| LEO Pharma Investigational Site | Toledo | Ohio | 43617 | — |
| LEO Pharma Investigational Site | Tulsa | Oklahoma | 74136 | — |
| LEO Pharma Investigational Site | Portland | Oregon | 97210 | — |
| LEO Pharma Investigational Site | Portland | Oregon | 97223 | — |
| LEO Pharma Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| LEO Pharma Investigational Site | North Charleston | South Carolina | 29420 | — |
| LEO Pharma Investigational Site | Goodlettsville | Tennessee | 37072 | — |
| LEO Pharma Investigational Site | Austin | Texas | 78759 | — |
| LEO Pharma Investigational Site | Bellaire | Texas | 77401 | — |
| LEO Pharma Investigational Site | Dallas | Texas | 75225 | — |
| LEO Pharma Investigational Site | Frisco | Texas | 75034 | — |
| LEO Pharma Investigational Site | Houston | Texas | 77004 | — |
| LEO Pharma Investigational Site | Pflugerville | Texas | 78660 | — |
| LEO Pharma Investigational Site | San Antonio | Texas | 78213 | — |
| LEO Pharma Investigational Site | San Antonio | Texas | 78218 | — |
| LEO Pharma Investigational Site | Webster | Texas | 77598 | — |
| LEO Pharma Investigational Site | South Burlington | Vermont | 05403 | — |
| LEO Pharma Investigational Site | Norfolk | Virginia | 23502 | — |
| LEO Pharma Investigational Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 214 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03587805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03587805 live on ClinicalTrials.gov.